They found that EGCG reduced CRC progression in HT‐29 cell lines by activating the PERK/p‐eIF2α/ATF4/IRE1α axis and induced apoptosis by caspase 3/7 activity. The gene discussed is CASP3; the disease is colorectal carcinoma.